Daniel N. Swisher, Jr
2015 - Sunesis Pharmaceuticals
In 2015, Daniel N. Swisher, Jr earned a total compensation of $1.2M as CEO and President at Sunesis Pharmaceuticals, a 49% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $206,300 |
|---|---|
| Option Awards | $522,720 |
| Salary | $498,333 |
| Other | $3,466 |
| Total | $1,230,819 |
Swisher received $522.7K in option awards, accounting for 42% of the total pay in 2015.
Swisher also received $206.3K in non-equity incentive plan, $498.3K in salary and $3.5K in other compensation.
Rankings
In 2015, Daniel N. Swisher, Jr's compensation ranked 6,930th out of 13,638 executives tracked by ExecPay. In other words, Swisher earned more than 49.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,930 out of 13,638 | 49th |
Division Manufacturing | 2,621 out of 5,190 | 50th |
Major group Chemicals And Allied Products | 939 out of 1,854 | 49th |
Industry group Drugs | 754 out of 1,528 | 51st |
Industry Pharmaceutical Preparations | 586 out of 1,182 | 50th |
Source: SEC filing on April 20, 2017.
Swisher's colleagues
We found one more compensation record of an executive who worked with Daniel N. Swisher, Jr at Sunesis Pharmaceuticals in 2015.
2015
Eric Bjerkholt
Sunesis Pharmaceuticals
Chief Financial Officer
News
Jazz Pharmaceuticals CEO Bruce Cozadd's 2021 pay jumps 25% to $16M
June 10, 2022
Jazz Pharmaceuticals CEO Bruce Cozadd's 2020 pay slips 15% to $13M
June 11, 2021
Jazz Pharmaceuticals CEO Bruce Cozadd's 2019 pay jumps 29% to $15M
June 12, 2020
Jazz Pharmaceuticals CEO Bruce Cozadd's 2018 pay rises 11% to $11M
June 14, 2019